chartexchange

LEQEMBI(R) Pen (Subcutaneous Formulation of LEQEMBI(R)) Now Available in Japan for Patients with Early Alzheimer's Disease

JCN Newswire | Nov 13, 2026 10:15 AM EST

Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that "LEQEMBI(R) Pen", the subcutaneous (SC) formulation of "LEQEMBI(R)" (generic name: lecanemab) has been launched in Japan.

Read original article